XTX Topco’s Immunovant IMVT Stock Holding History

XTX Topco’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.5M	Sell	90,758 -112,271	-55%	-$3.42M	0.05%	614
2026 Q1	$5.04M	Buy	203,029 +169,907	+513%	+$4.4M	0.09%	278
2025 Q4	$842K	Buy	33,122 +15,795	+91%	+$352K	0.02%	1155
2025 Q3	$279K	Sell	17,327 -63,861	-79%	-$1.03M	0.01%	1558
2025 Q2	$1.3M	Buy	+81,188	New	+$1.23M	0.05%	521
2025 Q1	–	Sell	-22,740	Closed	-$563K	–	2712
2024 Q4	$563K	Buy	+22,740	New	+$645K	0.05%	671
2024 Q2	–	Sell	-9,237	Closed	-$298K	–	2141
2024 Q1	$298K	Buy	+9,237	New	+$337K	0.04%	863
2023 Q2	–	Sell	-20,548	Closed	-$319K	–	1603
2023 Q1	$319K	Buy	+20,548	New	+$357K	0.07%	602
2021 Q4	–	Sell	-15,418	Closed	-$134K	–	834
2021 Q3	$134K	Buy	+15,418	New	+$139K	0.05%	541

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

XTX Topco's IMVT Position: Q2 2026 in Review

XTX Topco reduced its Immunovant (IMVT) stake by 55% in Q2 2026, selling an estimated $3.42M and leaving 90,758 shares worth $3.5M. The position accounts for 0.05% of the portfolio, ranked #614.

XTX Topco first reported a position in IMVT in Q3 2021 and has held it in 9 quarters since. The position peaked at $5.04M in Q1 2026. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

XTX Topco held 90,758 shares of Immunovant worth $3.5M as of Q2 2026.
XTX Topco sold 112,271 Immunovant shares in Q2 2026, an estimated $3.42M.
Immunovant made up 0.05% of XTX Topco's portfolio in Q2 2026, its #614 holding.
XTX Topco first reported a position in Immunovant in Q3 2021 and has held it in 9 quarters since.
XTX Topco's Immunovant position peaked at $5.04M in Q1 2026.
226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.